262 related articles for article (PubMed ID: 14764597)
1. Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
Sharma C; Pradeep A; Pestell RG; Rana B
J Biol Chem; 2004 Apr; 279(17):16927-38. PubMed ID: 14764597
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
Sharma C; Pradeep A; Wong L; Rana A; Rana B
J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
[TBL] [Abstract][Full Text] [Related]
3. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
Liu J; Farmer SR
J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Kitamura S; Miyazaki Y; Hiraoka S; Nagasawa Y; Toyota M; Takakura R; Kiyohara T; Shinomura Y; Matsuzawa Y
Int J Cancer; 2001 Nov; 94(3):335-42. PubMed ID: 11745411
[TBL] [Abstract][Full Text] [Related]
5. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.
Pradeep A; Sharma C; Sathyanarayana P; Albanese C; Fleming JV; Wang TC; Wolfe MM; Baker KM; Pestell RG; Rana B
Oncogene; 2004 Apr; 23(20):3689-99. PubMed ID: 15116100
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.
Wang C; Fu M; D'Amico M; Albanese C; Zhou JN; Brownlee M; Lisanti MP; Chatterjee VK; Lazar MA; Pestell RG
Mol Cell Biol; 2001 May; 21(9):3057-70. PubMed ID: 11287611
[TBL] [Abstract][Full Text] [Related]
7. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H
J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
[TBL] [Abstract][Full Text] [Related]
10. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
[TBL] [Abstract][Full Text] [Related]
11. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
Yin F; Wakino S; Liu Z; Kim S; Hsueh WA; Collins AR; Van Herle AJ; Law RE
Biochem Biophys Res Commun; 2001 Sep; 286(5):916-22. PubMed ID: 11527386
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y
Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107
[TBL] [Abstract][Full Text] [Related]
14. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Takahashi Y; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Int J Oncol; 2003 Aug; 23(2):325-31. PubMed ID: 12851681
[TBL] [Abstract][Full Text] [Related]
16. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism.
Boulon S; Dantonel JC; Binet V; Vié A; Blanchard JM; Hipskind RA; Philips A
Mol Cell Biol; 2002 Nov; 22(22):7769-79. PubMed ID: 12391146
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
Ghosh SS; Gehr TW; Ghosh S; Fakhry I; Sica DA; Lyall V; Schoolwerth AC
Kidney Int; 2003 Jul; 64(1):52-62. PubMed ID: 12787395
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
20. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.
Tien ES; Davis JW; Vanden Heuvel JP
J Biol Chem; 2004 Jun; 279(23):24053-63. PubMed ID: 15051727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
